Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.360
+0.130 (5.83%)
At close: Feb 19, 2026, 4:00 PM EST
2.344
-0.016 (-0.69%)
After-hours: Feb 19, 2026, 5:28 PM EST
Nkarta Market Cap
Nkarta has a market cap or net worth of $167.63 million as of February 19, 2026. Its market cap has increased by 9.47% in one year.
Market Cap
167.63M
Enterprise Value
-35.94M
1-Year Change
9.47%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $167.63M, a decrease of -88.55%. That is a compound annual growth rate of -32.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 158.40M | 20.54% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 149.41M |
| Caribou Biosciences | 147.68M |
| Connect Biopharma Holdings | 145.35M |
| Fate Therapeutics | 144.19M |
| Sangamo Therapeutics | 143.80M |
| Tenaya Therapeutics | 142.89M |
| Corbus Pharmaceuticals Holdings | 140.08M |
| ProMIS Neurosciences | 136.76M |